1. Home
  2. VERU vs OPAD Comparison

VERU vs OPAD Comparison

Compare VERU & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VERU
  • OPAD
  • Stock Information
  • Founded
  • VERU 1971
  • OPAD 2015
  • Country
  • VERU United States
  • OPAD United States
  • Employees
  • VERU N/A
  • OPAD N/A
  • Industry
  • VERU Biotechnology: Pharmaceutical Preparations
  • OPAD Real Estate
  • Sector
  • VERU Health Care
  • OPAD Finance
  • Exchange
  • VERU Nasdaq
  • OPAD Nasdaq
  • Market Cap
  • VERU 107.2M
  • OPAD 99.9M
  • IPO Year
  • VERU 1990
  • OPAD N/A
  • Fundamental
  • Price
  • VERU $0.58
  • OPAD $3.73
  • Analyst Decision
  • VERU Strong Buy
  • OPAD Hold
  • Analyst Count
  • VERU 4
  • OPAD 5
  • Target Price
  • VERU $4.00
  • OPAD $5.33
  • AVG Volume (30 Days)
  • VERU 996.7K
  • OPAD 41.9K
  • Earning Date
  • VERU 12-06-2024
  • OPAD 11-04-2024
  • Dividend Yield
  • VERU N/A
  • OPAD N/A
  • EPS Growth
  • VERU N/A
  • OPAD N/A
  • EPS
  • VERU N/A
  • OPAD N/A
  • Revenue
  • VERU $14,091,909.00
  • OPAD $985,005,000.00
  • Revenue This Year
  • VERU N/A
  • OPAD N/A
  • Revenue Next Year
  • VERU N/A
  • OPAD $37.39
  • P/E Ratio
  • VERU N/A
  • OPAD N/A
  • Revenue Growth
  • VERU N/A
  • OPAD N/A
  • 52 Week Low
  • VERU $0.36
  • OPAD $2.57
  • 52 Week High
  • VERU $1.92
  • OPAD $11.22
  • Technical
  • Relative Strength Index (RSI)
  • VERU 24.06
  • OPAD 54.82
  • Support Level
  • VERU $0.72
  • OPAD $3.67
  • Resistance Level
  • VERU $0.83
  • OPAD $4.89
  • Average True Range (ATR)
  • VERU 0.06
  • OPAD 0.35
  • MACD
  • VERU -0.02
  • OPAD 0.10
  • Stochastic Oscillator
  • VERU 1.38
  • OPAD 42.72

About VERU Veru Inc.

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

About OPAD Offerpad Solutions Inc.

Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.

Share on Social Networks: